Men with the lowest testosterone levels had an 18% higher relative risk of dying from cancer than participants with the highest levels. This was shown by an analysis of data from more than 26,000 men. The study by a team from the University of Western Australia and their colleagues was published in The Lancet Healthy Longevity.
The researchers pooled the results of 11 observational studies. The included studies tracked men's health for at least five years and measured hormones using mass spectrometry. The analysis accounted for age, body weight, smoking, a history of cancer, and other factors.
The difference in mortality persisted when comparing the lowest and highest fifths of the testosterone distribution. The increase in risk was particularly pronounced at low hormone concentrations.
Lower levels of dihydrotestosterone, a related hormone, were also associated with a greater risk of dying from cancer. However, no association was found between total testosterone levels and the risk of developing prostate cancer.
The findings do not mean that hormone deficiency itself causes tumors or that taking the hormone prevents cancer. Low testosterone may reflect other health problems, and observational data cannot fully distinguish between the possible explanations.
The authors view hormone measurements as potential risk markers. Further research is needed to understand their practical significance and investigate causal mechanisms.










